Gottlieb A, Bechmann L, Canbay A

Language: English
References: 12
Page: 341-342
PDF size: 100.98 Kb.

ABSTRACT

Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease nowadays with currently no approved therapies for the disease. The liver plays a pivotal role in lipid and glucose metabolism. The interactions of molecular mechanisms on the gut for example influences the development still needs to be understood. Bile acids (BA) have been shown to impact metabolic homeostasis and insulin sensitivity. Here, we comment on a study analyzing BA profiles in NAFLD patients addressing novel pathways involved in NAFLD progression.

REFERENCES

1. Seyda Seydel G, Kucukoglu O, Altinbasv A, et al. Economic growth leads to increase of obesity and associated hepatocellular carcinoma in developing countries. Ann Hepatol 2016; 15: 662-72.

2. Faasse S, Braun H, Vos M. The role of NAFLD in cardiometabolic disease: An update. F1000Res 2018; 7: 170

3. Rinella ME. Nonalcoholic fatty liver disease: A systematic review. JAMA 2015; 313: 2263-73.

4. Matteoni CA, Younossi ZM, Gramlich T, et al. Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity. Gastroenterology 1999; 116: 1413-9.

5. Younossi ZM. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Implications for liver transplantation. Liver Transpl 2018; 24: 166-70.

6. Bhowmik S, Chiu H-P, Jones DH, et al. Structure and functional characterization of a bile acid 7á dehydratase BaiE in secondary bile acid synthesis. Proteins 2016; 84: 316-31.

7. Masuda N, Oda H, Hirano S, et al. Enhancement of the 7 alpha- dehydroxylase activity of a gram-positive intestinal anaerobe by flavins. Appl Environ Microbiol 1983; 45: 308-9.

8. Bechmann LP, Kocabayoglu P, Sowa J-P, et al. Free fatty acids repress small heterodimer partner (SHP) activation and adiponectin counteracts bile acid-induced liver injury in superobese patients with nonalcoholic steatohepatitis. Hepatology 2013; 57: 1394-406.

9. Ferslew BC, Xie G, Johnston CK, et al. Altered Bile Acid Metabolome in Patients with Nonalcoholic Steatohepatitis. Dig Dis Sci 2015; 60: 3318-28.

10. Mouzaki M, Wang AY, Bandsma R, et al. Bile Acids and Dysbiosis in Non-Alcoholic Fatty Liver Disease. PLoS ONE 2016; 11: e0151829.

11. Puri P, Daita K, Joyce A, et al. The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids. Hepatology; DOI: 10.1002/ hep.29359.

12. Legry V, Francque S, Haas JT, et al. Bile Acid Alterations Are Associated With Insulin Resistance, but Not With NASH, in Obese Subjects. J Clin Endocrinol Metab 2017; 102: 3783-94.